Ascelia Pharma AB (publ) (ACE) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.137x

Based on the latest financial reports, Ascelia Pharma AB (publ) (ACE) has a cash flow conversion efficiency ratio of -0.137x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-15.66 Million ≈ $-1.69 Million USD) by net assets (Skr114.40 Million ≈ $12.31 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Ascelia Pharma AB (publ) liquidity coverage in days to measure how many days the company can operate on defensive assets alone.

Ascelia Pharma AB (publ) - Cash Flow Conversion Efficiency Trend (2017–2024)

This chart illustrates how Ascelia Pharma AB (publ)'s cash flow conversion efficiency has evolved over time, based on yearly financial data.

Ascelia Pharma AB (publ) Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Ascelia Pharma AB (publ) ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
ALANDEQGRP FPO AU:AEG	-1.327x
InkTec Co. Ltd KQ:049550	0.033x
Lohakit Metal Public Company Limited BK:LHK	0.043x
HY Electronic Cayman Ltd TW:6573	0.298x
LORDS CHLORO ALKALI ORD T (BSE) NSE:LORDSCHLO	N/A
Persimmon PLC LSE:PSN	0.037x
Firetail Resources Ltd AU:FTL	-0.038x
NH SPAC 5 KQ:215790	-0.019x

Annual Cash Flow Conversion Efficiency for Ascelia Pharma AB (publ) (2017–2024)

The table below shows the annual cash flow conversion efficiency of Ascelia Pharma AB (publ) from 2017 to 2024. For the full company profile with market capitalisation and key ratios, see how much is Ascelia Pharma AB (publ) worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	Skr78.94 Million ≈ $8.50 Million	Skr-62.84 Million ≈ $-6.76 Million	-0.796x	+53.33%
2023-12-31	Skr74.33 Million ≈ $8.00 Million	Skr-126.79 Million ≈ $-13.64 Million	-1.706x	-146.30%
2022-12-31	Skr180.86 Million ≈ $19.46 Million	Skr-125.26 Million ≈ $-13.48 Million	-0.693x	-82.92%
2021-12-31	Skr307.83 Million ≈ $33.13 Million	Skr-116.56 Million ≈ $-12.54 Million	-0.379x	-4.51%
2020-12-31	Skr236.06 Million ≈ $25.40 Million	Skr-85.53 Million ≈ $-9.20 Million	-0.362x	-132.65%
2019-12-31	Skr237.06 Million ≈ $25.51 Million	Skr-36.92 Million ≈ $-3.97 Million	-0.156x	-41.74%
2018-12-31	Skr276.07 Million ≈ $29.71 Million	Skr-30.33 Million ≈ $-3.26 Million	-0.110x	+41.43%
2017-12-31	Skr111.73 Million ≈ $12.02 Million	Skr-20.96 Million ≈ $-2.26 Million	-0.188x	--

About Ascelia Pharma AB (publ)

ST:ACE Sweden Biotechnology

Market Cap

$41.03 Million

Skr381.24 Million SEK

Market Cap Rank

#22673 Global

#430 in Sweden

Share Price

Skr3.01

Change (1 day)

-0.83%

52-Week Range

Skr2.60 - Skr5.10

All Time High

Skr900.24